<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20130521//EN"
"http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="review-article" dtd-version="3.0" xml:lang="en"
	xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">JORM</journal-id>
			<journal-title-group>
				<journal-title>Journal of Oral &amp; Maxillofacial Research</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2029-283X</issn>
			<publisher>
				<publisher-name>Stilus Optimus</publisher-name>
				<publisher-loc>Kaunas, Lithuania</publisher-loc>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">v4n1e3ht</article-id>
			<article-id pub-id-type="doi">10.5037/jomr.2013.4103</article-id>
			<article-categories>
				<subj-group subj-group-type="article-type">
					<subject>Original Paper</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Myofibroblasts and Transforming Growth Factor-Beta1 in Reactive Gingival Overgrowths</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author" id="contrib1">
					<name>
						<surname>Epivatianos</surname>
						<given-names>Apostolos</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">1</xref>
				</contrib>
				<contrib contrib-type="author" id="contrib2"  corresp="yes">
					<name>
						<surname>Andreadis</surname>
						<given-names>Dimitrios</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">1</xref>
				</contrib>
				<contrib contrib-type="author" id="contrib3">
					<name>
						<surname>Iordanidis</surname>
						<given-names>Savas</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">1</xref>
				</contrib>
			</contrib-group>
            <aff id="aff1" rid="aff1">
			<sup>1</sup>
			<institution>Department of Oral Medicine and Oral Pathology, Dental School, Aristotle University of Thessaloniki</institution>
			<country>Greece.</country></aff>
			<author-notes>
				<corresp>Dimitrios Andreadis, 
					<institution>Department of Oral Medicine/Pathology, School of Dentistry</institution>
					<addr-line>Aristotle University of Thessaloniki, 54124</addr-line>
					<country>Greece</country>
					<phone>+302310-999538</phone>
					Fax: +302310-999532<email>dandrea@dent.auth.gr</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="collection">
			<season>Jan-Mar</season>
			<year>2013</year>
			</pub-date>
			<pub-date pub-type="epub">
				<day>1</day>
				<month>4</month>
				<year>2013</year>
				</pub-date>
			<volume>4</volume>
			<issue>1</issue>
			<elocation-id>e3</elocation-id>
				<history>
				<date date-type="received">
				<day>19</day>
				<month>3</month>
				<year>2013</year>
				</date>
				<date date-type="accepted">
				<day>29</day>
				<month>3</month>
				<year>2013</year>
				</date>
				</history>
			<permissions>
				<copyright-statement>Copyright &#169; Epivatianos A, Andreadis D, Iordanidis S. Published in the JOURNAL OF ORAL &amp; MAXILLOFACIAL
					RESEARCH (http://www.ejomr.org), 1 April 2013.</copyright-statement>
				<copyright-year>2013</copyright-year>
				<license license-type="open-access"
					xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
					<license-p>This is an open-access article, first published in the JOURNAL OF
						ORAL &amp; MAXILLOFACIAL RESEARCH, distributed under the terms of the
						Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported
						License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted non-commercial use, distribution, and
						reproduction in any medium, provided the original work and is properly
						cited. The copyright, license information and link to the original
						publication on http://www.ejomr.org must be included.</license-p>
				</license>
			</permissions>
			<self-uri xlink:href="http://www.ejomr.org/JOMR/archives/2013/1/e3/v4n1e3ht.htm"
				xlink:type="simple"/>
			<abstract>
			<title>ABSTRACT</title>
				<sec sec-type="objectives">
					<title>Objectives</title>
<p>The purpose of this study was to evaluate the oral health-related quality of 
life of patients treated with implant-supported mandibular overdentures and to compare 
the attachment systems used.</p>
				</sec>
				<sec sec-type="material and methods">
					<title>Material and Methods</title>
<p>The presence of myofibroblasts as well as transforming growth 
		factor-beta1 was examined in twenty cases of fibrous epulis and 22 
		ossifying fibrous epulis, using immunohistochemistry.</p>
				</sec>
				<sec sec-type="results">
					<title>Results</title>
<p>Myofibroblasts positive for alpha smooth muscle actin and vimentin but 
		negative to desmin were found in 20% and 45% in fibrous epulis and 
		ossifying fibrous epulis, respectively. Myofibroblasts were distributed 
		in areas with and without inflammatory infiltration and their presence 
		in inflammatory areas was not related with the degree of inflammatory 
		infiltration. A percentage of 21 - 60% of fibroblasts and chronic 
		inflammatory cells expressed transforming growth factor-beta1 in all 
		cases.</p>
				</sec>
				<sec sec-type="conclusions">
					<title>Conclusions</title>
<p>These data suggest that transforming growth factor-beta1 and 
		myofibroblasts contribute to the formation of collagenous connective 
		tissue in fibrous epulis and ossifying fibrous epulis. Myofibroblasts 
		are mainly presented in ossifying fibrous epulis than in fibrous epulis. 
		It seems to be no relationship between the presence of myofibroblasts 
		and the degree of inflammatory infiltration of the lesions.</p>
				</sec>
			</abstract>
			<kwd-group>
				<kwd>myofibroblasts</kwd>
				<kwd>transforming growth factor beta1</kwd>
				<kwd>epulis</kwd>
				<kwd>fibroma.</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
<p>Myofibroblasts (MFs) are specialized fibroblasts characterized by the 
		presence of contractile apparatus [<xref ref-type="bibr" rid="B1">1</xref>] and are responsible for 
		synthesizing enzymes involved in extracellular matrix degeneration, 
		tissue remodelling and wound healing [<xref ref-type="bibr" rid="B2">2</xref>]. Furthermore, these cells are 
		involved in several fibrotic diseases, such as pulmonary fibrosis, 
		interstitial lung fibrosis, liver cirrhosis, renal fibrosis and 
		scleroderma, thus being responsible for overproduction of extracellular 
		matrix molecules, such as collagen type I [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Although fibroblasts 
		are considered to be the main progenitor cells of MFs, pericytes and 
		vascular smooth muscle cells may be transformed into MFs [<xref ref-type="bibr" rid="B5">5</xref>].</p>
		<p>Transforming growth factor-beta (TGF-&#946;) is a large family of 
		structurally related growth and differentiation factors including 
		activins and bone morphogenic proteins. There are three TGF-&#946; isoforms, 
		TGF-&#946;1, TGF-&#946;2 and TGF-&#946;3 with distinct and overlapping activities, such 
		as control of mesenchymal cell proliferation and differentiation, wound 
		healing and extracellular matrix production [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. TGF-&#946;1 is present in 
		epithelia, connective tissue and mononuclear inflammatory cells [<xref ref-type="bibr" rid="B7">7</xref>]. It 
		is well documented that TGF-&#946;1 plays the principal role in the 
		trans-differentiation of fibroblasts into MFs [<xref ref-type="bibr" rid="B4">4</xref>], as well as 
		fibroblasts' proliferation and collagen secretion in pathologic 
		conditions [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>].</p>
		<p>Fibrous epulis (FE) or peripheral fibroma and ossifying fibrous epulis (OFE) 
		or peripheral ossifying fibroma consists of common reactive fibrous 
		overgrowths of the gingiva caused by chronic irritation. FE consists of 
		interlacing collagen bundles but areas with chronic inflammatory 
		infiltration may also be presented [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. On the other hand, OFE is 
		composed of high fibrocellular tissue containing little or plenty of 
		bone, cementum-like material, and dystrophic calcification and 
		peripherally, there is a less fibrocellular tissue that is infiltrated 
		by chronic inflammatory cells, mostly lymphocytes and plasma cells. The 
		stratified epithelium of the lesion may be ulcerated [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. 
		</p>
		<p>The expression of TGF-&#946;1 in both FE and OFE has not been investigated in 
		detail, so far. Few studies have focused on the presence of MFs. Their 
		controversial results were based on a small number of cases [<xref ref-type="bibr" rid="B13">13-15</xref>]. 
		Furthermore, the relation of MFs and the inflammatory infiltration was 
		described only in one study on FE [<xref ref-type="bibr" rid="B16">16</xref>].</p>
		<p>The aim of the present study was to detect immunohistochemically the 
		presence of myofibroblasts and transforming growth factor-beta1 in 
		fibrous and ossifying-fibrous epulis in an attempt to note their 
		possible contribution in the formation of collagenous connective tissue 
		of the lesions. Also, a possible relationship between the presence of 
		myofibroblasts and degree of inflammatory infiltration was examined.</p>
		</sec>
		<sec sec-type="materials|methods">
			<title>MATERIAL AND METHODS</title>
		<p>Twenty cases of FE and 22 cases of OFE were retrieved from the archives 
		of the Department of Oral Medicine and Oral Pathology, Dental School of 
		Aristotle University of Thessaloniki, Greece. Cases with and without 
		inflammatory infiltrations in both FE and OFE were included. Serial, 4 
		&#956;m sections from paraffin-embedded tissues stained with haematoxylin and 
		eosin (for the confirmation of diagnosis) and for immunohistochemistry, 
		as well. Patients had given informed consent and the whole study was 
		performed according to the Declaration of Helsinski II.</p>
		<p>The inflammatory infiltration was graded as absent, mild, moderate and 
		severe. In cases with different degrees of inflammatory infiltration, 
		the most frequent degree was recorded in association with the presence 
		of MFs.</p>
		<p>Monoclonal antibodies against alpha smooth muscle actin (alpha-SMA), 
		vimentin, and desmin and polyclonal antibody against TGF-&#946;1 were used. 
		Endogenous peroxidase activity was quenched with 3% H<sub>2</sub>O<sub>2</sub> 
		for 10 min at room temperature. Then the sections were pre-treated for 
		antigen retrieval (<xref ref-type="table" rid="T1">Table 1</xref>). Sections that were intended for the 
		detection of alpha-SMA, vimentin and desmin were incubated with normal 
		rabbit serum, and those for the detection of TGF-&#946;1 with normal mouse 
		serum at a dilution of 1:20 for 30 min at room temperature. Sections 
		were incubated with monoclonal and polyclonal antibodies (<xref ref-type="table" rid="T1">Table 1</xref>) and 
		sections incubated with normal mouse serum were used as negative 
		control. Envision/horse radish peroxidase (HRP) ChemMate/TechMate 
		detection system (Dako, Glostrup, Denmark) was performed for the 
		detection of all antigens using the autostainer Ventana (Ventana Med 
		Systems Inc Tuscon, AZ, USA), and the reaction was developed using 
		diaminobenzidine. Haematoxylin was used as counterstain. Sections from a 
		leiomyoma and placenta were used as positive control for desmin and 
		TGF-&#946;1, respectively.</p>
	<table-wrap id="T1" position="float">
		<label>Table 1</label>
		<caption>
		<p>Source, clone and pretreatment for antigen retrieval</p>
		</caption>
        <table width="740" frame="hsides" rules="groups">
<thead>
  <tr> <th> Antibody </th> <th> Source </th> <th> Clone </th> <th> Pretreatment </th> <th> Dilution </th> <th> Incubation<break />
    (min) </th> </tr>
  </thead><tbody>
  <tr>
    <td align="center"> Alpha smooth muscle actin </td>
    <td align="center"> Dako, Glostrup, Denmark </td>
    <td align="center"> 1A4 </td>
    <td align="center"> No treatment </td>
    <td align="center"> 1:100 </td>
    <td align="center"> 30 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> Vimentin </td>
    <td align="center"> Dako, Glostrup, Denmark </td>
    <td align="center"> V9 </td>
    <td align="center"> Microwave<break />
      Citrate buffer 0.01M<break />
      pH 7.2 ,95&#176;C, 15 min</td>
    <td align="center"> 1:100 </td>
    <td align="center"> 30 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> Desmin </td>
    <td align="center"> BioCare, Carmino Diablo,<break />
      CA, USA </td>
    <td align="center"> D33 </td>
    <td align="center"> Microwave<break />
      Citrate buffer 0.01M<break />
      pH 7.2, 95&#176;C, 15 min</td>
    <td align="center"> 1:100 </td>
    <td align="center"> 30 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> Transforming<break />
      growth factor-beta1 </td>
    <td align="center"> Spinge Biosense, Pleasaton,<break />
      CA, USA </td>
    <td align="center"> Polyclonal </td>
    <td align="center"> Microwave<break />
      Citrate buffer 0.01M<break />
      pH 6, 95&#176;C, 10 min</td>
    <td align="center"> 1:25 </td>
    <td align="center"> 30 </td>
  </tr>
  </tbody>
</table>
			</table-wrap>

		<p>alpha-SMA and desmin were used in conjunction with morphology to 
		identify MFs, which are usually appeared as spindle shaped and sometimes 
		stellate. MFs' presence was counted as a percentage of all spindle 
		shaped and stellate cells, as reported previously [<xref ref-type="bibr" rid="B14">14</xref>]: (0) no staining, 
		(+) weak staining of 1% - 20% of all spindle shaped and stellate cells, 
		(++) intense staining of 21% - 60% spindle shaped and stellate cells and 
		(+++) intense staining of more than 60% of spindle shaped and stellate 
		cells. Fibroblasts and inflammatory cells expressing TGF-&#946;1 were 
		evaluated together using the method mentioned above. Five hundred cells 
		from 5 fields of each section were enumerated as the percentage of 
		positive MFs and cells expressing TGF-&#946;1. Sections were examined by two 
		of the authors (AE, DA) independently of each other. Sections were 
		re-examined when there were differences, and discussion was occasionally 
		necessary to establish uniformity.</p>
		
		<p><bold>Statistical analysis</bold></p>
		<p>Statistical analysis was performed using the chi-squared test (x<sup>2</sup>) 
		and statistical significance level was defined at P = 0.05.</p>
					</sec>
		<sec sec-type="results">
			<title>RESULTS</title>
		<p>MFs positive for alpha-SMA and vimentin but negative for desmin were 
		found in 4 of 20 cases (20%) of FE. Half of the cases did not contain 
		inflammatory cells and 2 of these cases showed a percentage of intense 
		presence of MFs (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In the rest 10 cases of FE, where areas 
		with and without inflammatory cells were concurrently presented in the 
		same case, two of the cases with weak and intense presence of MFs were 
		observed, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). The inflammatory infiltration in these 
		cases consisted of plasma cells lymphocytes and occasionally macrophages 
		(<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p>
		  <fig id="fig1">
  <label>Figure 1</label> <caption>
  <p>Fibrous epulis. A = myofibroblasts positive for alpha smooth 
				muscle actin in area without inflammatory infiltration. B = in 
				area with severe inflammatory infiltrate (hematoxylin and eosin 
				stain, original magnification x100).</p>
  </caption>
  <graphic xlink:href="jomr-04-e3-g001.jpg"/>
  </fig>
    				
	<table-wrap id="T2" position="float">
		<label>Table 2</label>
		<caption>
		<p>Presence of myofibroblasts (MFs) in different areas of 10 cases 
				of fibrous epulis</p>
		</caption>
        <table width="710" frame="hsides" rules="groups">
<thead>
  <tr> <th> </th> <th> Number of cases<break />
    with MFs </th> <th> Number of cases </th> <th> Degree of inflammatory<break />
    infiltration </th> </tr>
  </thead><tbody>
  <tr>
    <td  rowspan="3"><bold>Areas with inflammatory infiltration</bold></td>
    <td align="center"> 1 </td>
    <td align="center"> 5 </td>
    <td align="center"> Mild </td>
  </tr>
  <tr>
    <td colspan="3"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 1 </td>
    <td align="center"> 5 </td>
    <td align="center"> Moderate </td>
  </tr>
  <tr>
    <td colspan="4"><hr/></td>
  </tr>
  <tr>
    <td><bold>Areas without inflammatory infiltration</bold></td>
    <td align="center"> 2 </td>
    <td align="center"> 10 </td>
    <td align="center"> Absent </td>
  </tr>
  </tbody>
</table>
			</table-wrap>
		
        <p>Inflammatory infiltration and MFs were not found in 5 of 22 cases of OFE. 
		In the other 17 cases of OFE, in the periphery of the central, highly 
		fibrocellular and mizeralized part of the lesion, chronic inflammatory 
		infiltration from plasma cells, lymphocytes and occasional macrophages 
		could be observed. The presence or absence of MFs in the central part 
		and areas with different degrees of inflammatory infiltration around the 
		central part, as well as the percentages of MFs in 17 cases of OFE are 
		presented in <xref ref-type="table" rid="T3">Table 3</xref> and appeared in 
		<xref ref-type="fig" rid="fig2">Figure 2</xref>A, B. Although, the 
		frequency of MFs between FE and OFE was statistically significant (P &lt; 
		0.001), however, the presence of MFs in areas with inflammatory cells 
		was not related to the degree of inflammatory infiltration in both FE 
		and OFE (<xref ref-type="table" rid="T2">Tables 2</xref> and 
		<xref ref-type="table" rid="T3">3</xref>).</p>
		<table-wrap id="T3" position="float">
		<label>Table 3</label>
		<caption>
		<p>Myofibroblasts (MFs) in different areas of 17 cases of ossifying 
				fibrous epulis, degrees of inflammatory infiltration and 
				percentage of myofibroblasts</p>
		</caption>
       <table width="815" frame="hsides" rules="groups">
 <thead>
  <tr> <th> N </th> <th> MFs in<break />
    the central part </th> <th> MFs in areas<break />
    without inflammatory infiltration<break />
    around the central part </th> <th> MFs in areas<break />
    with inflammatory infiltration<break />
    around the central part </th> <th> Degree of inflammatory<break />
    infiltration </th> <th> MFs<break />
    (%) </th> </tr>
	</thead><tbody>
  <tr>
    <td align="center"> 3 </td>
    <td align="center"> - </td>
    <td align="center"> - </td>
    <td align="center"> - </td>
    <td align="center"> mild </td>
    <td align="center"> 0 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 4 </td>
    <td align="center"> - </td>
    <td align="center"> - </td>
    <td align="center"> - </td>
    <td align="center"> severe </td>
    <td align="center"> 0 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 1 </td>
    <td align="center"> - </td>
    <td align="center"> + </td>
    <td align="center"> + </td>
    <td align="center"> mild </td>
    <td align="center"> 1 - 20 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 2 </td>
    <td align="center"> + </td>
    <td align="center"> - </td>
    <td align="center"> + </td>
    <td align="center"> mild </td>
    <td align="center"> 1 - 20 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 2 </td>
    <td align="center"> + </td>
    <td align="center"> - </td>
    <td align="center"> + </td>
    <td align="center"> moderate </td>
    <td align="center"> 1 - 20 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 3 </td>
    <td align="center"> + </td>
    <td align="center"> + </td>
    <td align="center"> + </td>
    <td align="center"> severe </td>
    <td align="center"> 21 - 60 </td>
  </tr>
  <tr>
    <td colspan="6"><hr/></td>
  </tr>
  <tr>
    <td align="center"> 2 </td>
    <td align="center"> + </td>
    <td align="center"> + </td>
    <td align="center"> - </td>
    <td align="center"> moderate </td>
    <td align="center"> 21 - 60 </td>
  </tr>
  </tbody>
</table>
				<table-wrap-foot>
					<fn>
		<p>N = number of cases.</p>
				  </fn>
			  </table-wrap-foot>
			</table-wrap>

  <fig id="fig2">
  <label>Figure 2</label> <caption>
  <p>Ossifying fibrous epulis. A = myofibroblasts positive for alpha 
				smooth muscle actin in central area 
				(hematoxylin and 
				eosin stain, original magnification x200). 
				B = Beyond the vessels, no positive for alpha smooth muscle 
				actin myofibroblasts are presented in area with severe 
				inflammatory infiltrate around the central area of the lesion
				(hematoxylin and eosin stain, original magnification x100).</p>
  </caption>
  <graphic xlink:href="jomr-03-e4-g002.jpg"/>
  </fig>
  
		<p>TGF-&#946;1 expression was intensely seen in fibroblasts, plasma cells, 
		lymphocytes and macrophages in both FE and OFE (<xref ref-type="fig" rid="fig3">Figure 3</xref>A, B). Also, a 
		percentage of 21 - 60% of cells expressing TGF-&#946;1 was found in all 
		examined cases.</p>

  <fig id="fig3">
  <label>Figure 3</label> <caption>
  <p>Fibroblasts and inflammatory cells express transforming growth 
				factor-beta 1 in areas with chronic inflammatory infiltrate. A = 
				fibrous epulis. B = ossifying fibrous epulis 
				(hematoxylin and 
				eosin stain, original magnification x100).</p>
  </caption>
  <graphic xlink:href="jomr-03-e4-g003.jpg"/>
  </fig>

					</sec>
		<sec sec-type="discussion">
			<title>DISCUSSION</title>
		<p>The results of the current study showed that MFs and TGF-&#946;1 are likely 
		involved in the collagen formation in FE and OFE, but in contrast no 
		relationship was found between the presence of MFs and the degree of 
		inflammatory infiltration in both FE and OFE. Immunohistochemically, MFs 
		may have a variable phenotype including those that express only vimentin 
		(V type); vimentin and alpha-SMA (VA type); vimentin, alpha-SMA and 
		desmin (VAD type) and vimentin, alpha-SMA, smooth muscle myosin heavy 
		chains and/no desmin (VAM or VAMD type). The expression of alpha-SMA is 
		considered to be the main biochemical marker of myofibroblastic 
		differentiation [<xref ref-type="bibr" rid="B17">17</xref>]. In 
		the current study the detection of MFs was based on the combined 
		immunohistochemical profile (vimentin and alpha-SMA) as well as their morphology indicating that MFs of FE and OFE belong to the VA type. 
		Interestingly, the presence of MFs in FE has not been reported in 
		previous studies [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. This finding could be explained by the small 
		number of cases in previous studies and differences in the immunohistochemical procedure. The findings of the present study 
		regarding OFE are in accordance to a previous study by Garcia de Marcos 
		et al. [<xref ref-type="bibr" rid="B14">14</xref>] that reported the presence of MFs positive for vimentin and 
		alpha-SMA, whereas, Damasceno et al. [<xref ref-type="bibr" rid="B15">15</xref>] did not reveal the presence of MFs. The results of our study suggest that MFs may contribute in the 
		formation of collagenous connective tissue more frequently in OFE than 
		in FE.</p>
		<p>FE is considered to originate from mesenchymal cells of gingival and 
		periosteum [<xref ref-type="bibr" rid="B11">11</xref>], and OFE is considered to originate from cells of 
		periodontal ligament and periosteum [<xref ref-type="bibr" rid="B12">12</xref>]. Although immunohistochemical 
		studies did not reveal the presence of MFs [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B18">18</xref>], cell cultures of 
		fibroblasts from healthy gingiva and periodontal ligament demonstrated 
		that a few cells express alpha-SMA [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. It remains to be determined 
		whether the alpha-SMA positive cells in gingiva and periodontal ligament 
		represent a permanent or modulated fibroblastic population. 
		Differentiation from fibroblast into MF phenotype has been proposed to 
		be dependent on local environmental cues, including accumulation of 
		biologically active TGF-&#946;1 [<xref ref-type="bibr" rid="B20">20</xref>], extracellular matrix-integrin 
		interactions [<xref ref-type="bibr" rid="B21">21</xref>] and mechanical stress [<xref ref-type="bibr" rid="B1">1</xref>]. The reverse 
		MF-to-fibroblast differentiation is also possible under insulin-like 
		growth factor-1 [<xref ref-type="bibr" rid="B22">22</xref>], and basic fibroblast growth factor influence [<xref ref-type="bibr" rid="B23">23</xref>]. 
		Possibly the absence of MFs in many of our cases may be due to 
		alterations or lack of local environmental cues, or the presence of 
		insulin like growth factor-1 and/or basic fibroblast growth factor.</p>
		<p>TGF-&#946;1 is believed to participate in fibroblastic differentiation and 
		alpha &#945;-SMA expression in fibroblasts <italic>in vitro</italic> and <italic>in vivo</italic> 
		[<xref ref-type="bibr" rid="B1">1</xref>]. Connective tissue cells, macrophages, neutrophils, lymphocytes and 
		plasma cells express TGF-&#946;1 [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B24">24</xref>] that has paracrine and autocrine 
		effect [<xref ref-type="bibr" rid="B5">5</xref>]. Our results showed that MFs were not always present in areas 
		containing different degree of inflammatory infiltration. Similar 
		findings were reported in another study of FE, as well [<xref ref-type="bibr" rid="B16">16</xref>]. These 
		results suggest that TGF-&#946;1 of chronic inflammatory cells possibly is 
		not always involved in the recruitment of mesenchymal cells and their 
		trans-differentiation into MFs. Noteworthy, MFs were constantly 
		presented in cases with different degree of chronic inflammatory 
		infiltrate in obstructive pancreatitis [<xref ref-type="bibr" rid="B25">25</xref>], whereas in oral squamous 
		cell carcinoma, MFs tended to be inversely related to the infiltration 
		with mononuclear inflammatory cells [<xref ref-type="bibr" rid="B26">26</xref>]. Extracellular matrix molecules 
		and cytokines may affect the bioactivity of TGF-&#946;1. Fibronectin domain 
		ED-A is crucial for myofibroblastic phenotype induction [<xref ref-type="bibr" rid="B27">27</xref>], whereas decorin, tumour necrosis factor-&#945;, interferon-&#947;, and interleukin-1 
		inhibit the trans-differentiation of MFs [<xref ref-type="bibr" rid="B28">28-31</xref>].</p>
		<p>In the current study 21 - 60% of fibroblasts and chronic inflammatory 
		cells found to express TGF-&#946;1 in all cases of FE and OFE. This result 
		may indicate that there was not relationship between the presence of MFs 
		and percentage of cells expressing TGF-&#946;1. Although the expression of 
		TGF-&#946;1 was similar in all examined cases of FE and OFE, it can be 
		hypothesized that the absence of MFs in many cases may be due to the 
		lack of other than TGF-&#946;1 local environmental cues, or presence of 
		extracellular matrix molecules/cytokines affecting TGF-&#946;1 bioactivity. 
		Further investigation is needed to examine the local environmental cues 
		and growth factors/cytokines implication in the differentiation of MFs 
		in FE and OFE. TGF-&#946;1 has a marked effect on exracellular matrix 
		composition by attracting fibroblasts and leading to the synthesis and 
		secretion of extracellular matrix molecules, such as collagen type I, 
		fibronectin and tenascin [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. It is possible that autocrine and/or 
		paracrine effect of TGF-&#946;1 of fibroblasts cause collagen overproduction, 
		as well.</p>
					</sec>
		<sec sec-type="conclusions">
			<title>CONCLUSIONS</title>
		<p>The results of the present study suggest that transforming growth 
		factor-beta1 likely contributes in the formation of collagenous 
		connective tissue in fibrous epulis and ossifying fibrous epulis, 
		whereas myofibroblasts more often in ossifying fibrous epulis than in 
		fibrous epulis. Also, there is no obvious relationship between the 
		presence of myofibroblasts and the degree of inflammatory infiltration 
		in both fibrous epulis and ossifying fibrous epulis.</p>
		</sec>
	</body>
	<back>
		<ack>
			<sec sec-type="acknowledgments and disclosure statements">
				<title>ACKNOWLEDGMENTS AND DISCLOSURE STATEMENTS</title>
		<p>The authors declare that they have no conflict of interests.</p>
			</sec>
		</ack>
		<ref-list>
		<title>REFERENCES</title>
<ref id="B1"><label>1</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Tomasek</surname>
							<given-names>JJ</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>G</given-names>
                            </name><name>
                            <surname>Hinz</surname>
							<given-names>B</given-names>
                            </name><name>
                            <surname>Chaponnier</surname>
							<given-names>C</given-names>
                            </name><name>
                            <surname>Brown</surname>
							<given-names>RA</given-names>
						</name>
					</person-group>
					<source>Myofibroblasts and mechano-regulation 
of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002 May;3(5):349-63. Review.</source>
        <pub-id pub-id-type="pmid">11988769</pub-id>
<pub-id pub-id-type="doi">10.1038/nrm809</pub-id>
  </element-citation>
</ref>
<ref id="B2"><label>2</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Guyot</surname>
							<given-names>C</given-names>
                            </name><name>
                            <surname>Lepreux</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Combe</surname>
							<given-names>C</given-names>
                            </name><name>
                            <surname>Doudnikoff</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Bioulac-Sage</surname>
							<given-names>P</given-names>
                            </name><name>
                            <surname>Balabaud</surname>
							<given-names>C</given-names>
                            </name><name>
                            <surname>Desmouli&#232;re</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<source>Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. 
Int J Biochem Cell Biol. 2006 Feb;38(2):135-51. Epub 2005 Sep 23. Review.</source>
        <pub-id pub-id-type="pmid">16257564</pub-id>
    <pub-id pub-id-type="doi">10.1016/j.biocel.2005.08.021</pub-id>
  </element-citation>
</ref>
<ref id="B3"><label>3</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Schmitt-Gräff</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Desmouli&#232;re</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<source>Heterogeneity of myofibroblast phenotypic 
features: an example of fibroblastic cell plasticity. Virchows Arch. 1994;425(1):3-24. 
Review.</source>
        <pub-id pub-id-type="pmid">7921410</pub-id>
<pub-id pub-id-type="doi">10.1007/BF00193944</pub-id>
  </element-citation>
</ref>
<ref id="B4"><label>4</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Zhang</surname>
							<given-names>K</given-names>
                            </name><name>
                            <surname>Rekhter</surname>
							<given-names>MD</given-names>
                            </name><name>
                            <surname>Gordon</surname>
							<given-names>D</given-names>
                            </name><name>
                            <surname>Phan</surname>
							<given-names>SH</given-names>
						</name>
					</person-group>
					<source>Myofibroblasts and their role in lung 
collagen gene expression during pulmonary fibrosis. A combined immunohistochemical 
and in situ hybridization study. Am J Pathol. 1994 Jul;145(1): 114-25.</source>
        <pub-id pub-id-type="pmid">7518191</pub-id>
    <pub-id pub-id-type="pmcid">PMC1887314</pub-id>
  </element-citation>
</ref>
<ref id="B5"><label>5</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>De Wever</surname>
							<given-names>O</given-names>
                            </name><name>
                            <surname>Mareel</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<source>Role of tissue stroma in cancer cell invasion. J Pathol. 
2003 Jul;200(4):429-47. Review.</source>
        <pub-id pub-id-type="pmid">12845611</pub-id>
    <pub-id pub-id-type="doi">10.1002/path.1398</pub-id>
  </element-citation>
</ref>
<ref id="B6"><label>6</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Massagué</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<source>The transforming growth factor-beta family. Annu Rev Cell Biol. 
1990;6:597-641. Review.</source>
        <pub-id pub-id-type="pmid">2177343</pub-id>
    <pub-id pub-id-type="doi">10.1146/annurev.cb.06.110190.003121</pub-id>
  </element-citation>
</ref>
<ref id="B7"><label>7</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Massagué</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<source>TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753-91. 
Review.</source>
        <pub-id pub-id-type="pmid">9759503</pub-id>
    <pub-id pub-id-type="doi">10.1146/annurev.biochem.67.1.753</pub-id>
  </element-citation>
</ref>
<ref id="B8"><label>8</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Kondo</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Kagami</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Urushihara</surname>
							<given-names>M</given-names>
                            </name><name>
                            <surname>Kitamura</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Shimizu</surname>
							<given-names>M</given-names>
                            </name><name>
                            <surname>Strutz</surname>
							<given-names>F</given-names>
                            </name><name>
                            <surname>Müller</surname>
							<given-names>GA</given-names>
                            </name><name>
                            <surname>Kuroda</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<source>Transforming growth factor-beta1 stimulates collagen matrix remodeling  
through increased adhesive and contractive potential by human renal fibroblasts.  
Biochim Biophys Acta. 2004 Aug 23;1693(2):91-100.</source>
        <pub-id pub-id-type="pmid">15313011</pub-id>
    <pub-id pub-id-type="doi">10.1016/j.bbamcr.2004.05.005</pub-id>
  </element-citation>
</ref>
<ref id="B9"><label>9</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Zeisberg</surname>
							<given-names>M</given-names>
                            </name><name>
                            <surname>Kalluri</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<source>Cellular mechanisms of tissue fibrosis. 1. Common and 
organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol. 
2013 Feb 1;304(3):C216-25. Epub 2012 Dec 19.</source>
        <pub-id pub-id-type="pmid">23255577</pub-id>
    <pub-id pub-id-type="doi">10.1152/ajpcell.00328.2012</pub-id>
  </element-citation>
</ref>
<ref id="B10"><label>10</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Lee</surname>
							<given-names>KW</given-names>
						</name>
					</person-group>
					<source>The fibrous epulis and related lesions. Granuloma pyogenicum, &#39;Pregnancy 
tumour&#39;, fibro-epithelial polyp and calcifying fibroblastic granuloma. A clinico-pathological 
study. Periodontics. 1968 Dec;6(6):277-92.</source>
        <pub-id pub-id-type="pmid">5248843</pub-id>
  </element-citation>
</ref>
<ref id="B11"><label>11</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Zain</surname>
							<given-names>RB</given-names>
                            </name><name>
                            <surname>Fei</surname>
							<given-names>YJ</given-names>
						</name>
					</person-group>
					<source>Fibrous lesions of the gingiva: a histopathologic analysis 
of 204 cases. Oral Surg Oral Med Oral Pathol. 1990 Oct;70(4):466-70.</source>
        <pub-id pub-id-type="pmid">2120653</pub-id>
    <pub-id pub-id-type="doi">10.1016/0030-4220(90)90212-B</pub-id>
  </element-citation>
</ref>
<ref id="B12"><label>12</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Buchner</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Hansen</surname>
							<given-names>LS</given-names>
						</name>
					</person-group>
					<source>The histomorphologic spectrum of peripheral ossifying 
fibroma. Oral Surg Oral Med Oral Pathol. 1987 Apr;63(4):452-61.</source>
        <pub-id pub-id-type="pmid">3472146</pub-id>
    <pub-id pub-id-type="doi">10.1016/0030-4220(87)90258-1</pub-id>
  </element-citation>
</ref>
<ref id="B13"><label>13</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Lombardi</surname>
							<given-names>T</given-names>
                            </name><name>
                            <surname>Morgan</surname>
							<given-names>PR</given-names>
						</name>
					</person-group>
					<source>Immunohistochemical characterisation of odontogenic cysts 
with mesenchymal and myofilament markers. J Oral Pathol Med. 1995 Apr;24(4):170-6.</source>
        <pub-id pub-id-type="pmid">7783006</pub-id>
    <pub-id pub-id-type="doi">10.1111/j.1600-0714.1995.tb01160.x</pub-id>
  </element-citation>
</ref>
<ref id="B14"><label>14</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Garc&#237;a de Marcos</surname>
							<given-names>JA</given-names>
                            </name><name>
                            <surname>Garc&#237;a de Marcos</surname>
							<given-names>MJ</given-names>
                            </name><name>
                            <surname>Arroyo Rodr&#237;guez</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Chiarri Rodrigo</surname>
							<given-names>J</given-names>
                            </name><name>
                            <surname>Poblet</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<source>Peripheral ossifying fibroma: a clinical and immunohistochemical study 
of four cases. J Oral Sci. 2010 Mar;52(1):95-9.</source>
        <pub-id pub-id-type="pmid">20339239</pub-id> 
    <pub-id pub-id-type="doi">10.2334/josnusd.52.95</pub-id>
  </element-citation>
</ref>
<ref id="B15"><label>15</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Damasceno</surname>
							<given-names>LS</given-names>
                            </name><name>
                            <surname>Gon&#231;alves Fda</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Costa e Silva</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Zenóbio</surname>
							<given-names>EG</given-names>
                            </name><name>
                            <surname>Souza</surname>
							<given-names>PE</given-names>
                            </name><name>
                            <surname>Horta</surname>
							<given-names>MC</given-names>
						</name>
					</person-group>
					<source>Stromal myofibroblasts in focal reactive overgrowths of the gingiva. Braz Oral 
Res. 2012 Jul-Aug;26(4):373-7. Epub 2012 Jun 21.</source>
        <pub-id pub-id-type="pmid">22714931</pub-id>
    <pub-id pub-id-type="doi">10.1590/S1806-83242012005000012</pub-id>
  </element-citation>
</ref>
<ref id="B16"><label>16</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Filioreanu</surname>
							<given-names>AM</given-names>
                            </name><name>
                            <surname>Popescu</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Cotrutz</surname>
							<given-names>C</given-names>
                            </name><name>
                            <surname>Cotrutz</surname>
							<given-names>CE</given-names>
						</name>
					</person-group>
					<source>Immunohistochemical and transmission 
electron microscopy study regarding myofibroblasts in fibroinflammatory epulis and 
giant cell peripheral granuloma. Rom J Morphol Embryol. 2009;50(3):363-8.</source>
        <pub-id pub-id-type="pmid">19690761</pub-id>
  </element-citation>
</ref>
<ref id="B17"><label>17</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Schürch</surname>
							<given-names>W</given-names>
                            </name><name>
                            <surname>Seemayer</surname>
							<given-names>TA</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<source>The myofibroblast: a quarter century after 
its discovery. Am J Surg Pathol. 1998 Feb;22(2):141-7. Review.</source>
        <pub-id pub-id-type="pmid">9500214</pub-id>
    <pub-id pub-id-type="doi">10.1097/00000478-199802000-00001</pub-id>
  </element-citation>
</ref>
<ref id="B18"><label>18</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Sobral</surname>
							<given-names>LM</given-names>
                            </name><name>
                            <surname>Kellermann</surname>
							<given-names>MG</given-names>
                            </name><name>
                            <surname>Graner</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Martelli-Junior</surname>
							<given-names>H</given-names>
                            </name><name>
                            <surname>Coletta</surname>
							<given-names>RD</given-names>
						</name>
					</person-group>
					<source>Cyclosporin 
A-induced gingival overgrowth is not associated with myofibroblast transdifferentiation. 
Braz Oral Res. 2010 Apr-Jun;24(2):182-8.</source>
        <pub-id pub-id-type="pmid">20658037</pub-id>
    <pub-id pub-id-type="doi">10.1590/S1806-83242010000200010</pub-id>
  </element-citation>
</ref>
<ref id="B19"><label>19</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Arora</surname>
							<given-names>PD</given-names>
                            </name><name>
                            <surname>McCulloch</surname>
							<given-names>CA</given-names>
						</name>
					</person-group>
					<source>Dependence of collagen remodelling on alpha-smooth muscle 
actin expression by fibroblasts. J Cell Physiol. 1994 Apr;159(1):161-75.</source>
        <pub-id pub-id-type="pmid">8138584</pub-id>
    <pub-id pub-id-type="doi">10.1002/jcp.1041590120</pub-id>
  </element-citation>
</ref>
<ref id="B20"><label>20</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Desmouli&#232;re</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Geinoz</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>F</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<source>Transforming growth factor-beta 
1 induces alpha-smooth muscle actin expression in granulation tissue  myofibroblasts 
and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993 Jul;122(1):103-11.</source>
        <pub-id pub-id-type="pmid">8314838</pub-id> 
    <pub-id pub-id-type="doi">10.1083/jcb.122.1.103</pub-id>
    <pub-id pub-id-type="pmcid">PMC2119614</pub-id>
  </element-citation>
</ref>
<ref id="B21"><label>21</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Jester</surname>
							<given-names>JV</given-names>
                            </name><name>
                            <surname>Huang</surname>
							<given-names>J</given-names>
                            </name><name>
                            <surname>Petroll</surname>
							<given-names>WM</given-names>
                            </name><name>
                            <surname>Cavanagh</surname>
							<given-names>HD</given-names>
						</name>
					</person-group>
					<source>TGFbeta induced myofibroblast differentiation 
of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. 
Exp Eye Res. 2002 Dec;75(6):645-57.</source>
        <pub-id pub-id-type="pmid">12470966</pub-id>
    <pub-id pub-id-type="doi">10.1006/exer.2002.2066</pub-id>
  </element-citation>
</ref>
<ref id="B22"><label>22</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Simmons</surname>
							<given-names>JG</given-names>
                            </name><name>
                            <surname>Pucilowska</surname>
							<given-names>JB</given-names>
                            </name><name>
                            <surname>Keku</surname>
							<given-names>TO</given-names>
                            </name><name>
                            <surname>Lund</surname>
							<given-names>PK</given-names>
						</name>
					</person-group>
					<source>IGF-I and TGF-beta1 have distinct 
effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest 
Liver Physiol. 2002 Sep;283(3):G809-18.</source>
        <pub-id pub-id-type="pmid">12181198</pub-id>
    <pub-id pub-id-type="doi">10.1152/ajpgi.00057.2002</pub-id>
  </element-citation>
</ref>
<ref id="B23"><label>23</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Maltseva</surname>
							<given-names>O</given-names>
                            </name><name>
                            <surname>Folger</surname>
							<given-names>P</given-names>
                            </name><name>
                            <surname>Zekaria</surname>
							<given-names>D</given-names>
                            </name><name>
                            <surname>Petridou</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Masur</surname>
							<given-names>SK</given-names>
						</name>
					</person-group>
					<source>Fibroblast growthfactor 
reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci. 2001 
Oct;42(11):2490-5.</source>
        <pub-id pub-id-type="pmid">11581188</pub-id>
  </element-citation>
</ref>
<ref id="B24"><label>24</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Ho</surname>
							<given-names>CL</given-names>
                            </name><name>
                            <surname>Sheu</surname>
							<given-names>LF</given-names>
                            </name><name>
                            <surname>Li</surname>
							<given-names>CY</given-names>
						</name>
					</person-group>
					<source>Immunohistochemical expression of angiogenic cytokines 
and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann 
Diagn Pathol. 2003 Feb;7(1):1-8.</source>
        <pub-id pub-id-type="pmid">12616467</pub-id>
    <pub-id pub-id-type="doi">10.1053/adpa.2003.50000</pub-id>
  </element-citation>
</ref>
<ref id="B25"><label>25</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Fukumura</surname>
							<given-names>Y</given-names>
                            </name><name>
                            <surname>Kumasaka</surname>
							<given-names>T</given-names>
                            </name><name>
                            <surname>Mitani</surname>
							<given-names>K</given-names>
                            </name><name>
                            <surname>Karita</surname>
							<given-names>K</given-names>
                            </name><name>
                            <surname>Suda</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<source>Expression of transforming 
growth factor beta1, beta2, and beta3 in chronic, cancer-associated, obstructive  
pancreatitis. Arch Pathol Lab Med. 2006 Mar;130(3):356-61.</source>
        <pub-id pub-id-type="pmid">16519564</pub-id>
  </element-citation>
</ref>
<ref id="B26"><label>26</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Kellermann</surname>
							<given-names>MG</given-names>
                            </name><name>
                            <surname>Sobral</surname>
							<given-names>LM</given-names>
                            </name><name>
                            <surname>da Silva</surname>
							<given-names>SD</given-names>
                            </name><name>
                            <surname>Zecchin</surname>
							<given-names>KG</given-names>
                            </name><name>
                            <surname>Graner</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Lopes</surname>
							<given-names>MA</given-names>
                            </name><name>
                            <surname>Kowalski</surname>
							<given-names>LP</given-names>
                            </name><name>
                            <surname>Coletta</surname>
							<given-names>RD</given-names>
						</name>
					</person-group>
					<source>Mutual paracrine effects of oral squamous cell carcinoma cells and 
normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation 
and modulation of tumor cell proliferation. Oral Oncol. 2008 May;44(5):509-17. Epub 
2007 Sep 7.</source>
        <pub-id pub-id-type="pmid">17826300</pub-id>
    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2007.07.001</pub-id>
  </element-citation>
</ref>
<ref id="B27"><label>27</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Serini</surname>
							<given-names>G</given-names>
                            </name><name>
                            <surname>Bochaton-Piallat</surname>
							<given-names>ML</given-names>
                            </name><name>
                            <surname>Ropraz</surname>
							<given-names>P</given-names>
                            </name><name>
                            <surname>Geinoz</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Borsi</surname>
							<given-names>L</given-names>
                            </name><name>
                            <surname>Zardi</surname>
							<given-names>L</given-names>
                            </name><name>
                            <surname>Gabbiani</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<source>The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction 
by transforming growth factor-beta1. J Cell Biol. 1998 Aug 10;142(3):873-81.</source>
        <pub-id pub-id-type="pmid">9700173</pub-id>
    <pub-id pub-id-type="doi">10.1083/jcb.142.3.873</pub-id>
    <pub-id pub-id-type="pmcid">PMC2148176</pub-id>
  </element-citation>
</ref>
<ref id="B28"><label>28</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Scott</surname>
							<given-names>PG</given-names>
                            </name><name>
                            <surname>Dodd</surname>
							<given-names>CM</given-names>
                            </name><name>
                            <surname>Tredget</surname>
							<given-names>EE</given-names>
                            </name><name>
                            <surname>Ghahary</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Rahemtulla</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<source>Immunohistochemical 
localization of the proteoglycans decorin, biglycan and versican and transforming 
growth factor-beta in human post-burn hypertrophic and mature scars. Histopathology. 
1995 May;26(5):423-31.</source>
        <pub-id pub-id-type="pmid">7544762</pub-id>
    <pub-id pub-id-type="doi">10.1111/j.1365-2559.1995.tb00249.x</pub-id>
  </element-citation>
</ref>
<ref id="B29"><label>29</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Arancibia</surname>
							<given-names>R</given-names>
                            </name><name>
                            <surname>Oyarz&#250;n</surname>
							<given-names>A</given-names>
                            </name><name>
                            <surname>Silva</surname>
							<given-names>D</given-names>
                            </name><name>
                            <surname>Tobar</surname>
							<given-names>N</given-names>
                            </name><name>
                            <surname>Mart&#237;nez</surname>
							<given-names>J</given-names>
                            </name><name>
                            <surname>Smith</surname>
							<given-names>PC</given-names>
						</name>
					</person-group>
					<source>Tnf-&#945; Inhibits 
Tgf-&#946;-Stimulated Myofibroblastic Differentiation and Extracellular Matrix Production 
in Human Gingival Fibroblasts. J Periodontol. 2012 Jul 19. [Epub ahead of print]</source>
        <pub-id pub-id-type="pmid">22813343</pub-id>
    <pub-id pub-id-type="doi">10.1902/jop.2012.120225</pub-id>
  </element-citation>
</ref>
<ref id="B30"><label>30</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Sobral</surname>
							<given-names>LM</given-names>
                            </name><name>
                            <surname>Montan</surname>
							<given-names>PF</given-names>
                            </name><name>
                            <surname>Martelli-Junior</surname>
							<given-names>H</given-names>
                            </name><name>
                            <surname>Graner</surname>
							<given-names>E</given-names>
                            </name><name>
                            <surname>Coletta</surname>
							<given-names>RD</given-names>
						</name>
					</person-group>
					<source>Opposite effects 
of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival 
cell cultures. J Clin Periodontol. 2007 May;34(5):397-406. Epub 2007 Apr 2.</source>
        <pub-id pub-id-type="pmid">17403017</pub-id>
    <pub-id pub-id-type="doi">10.1111/j.1600-051X.2007.01063.x</pub-id>
  </element-citation>
</ref>
<ref id="B31"><label>31</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Shephard</surname>
							<given-names>P</given-names>
                            </name><name>
                            <surname>Martin</surname>
							<given-names>G</given-names>
                            </name><name>
                            <surname>Smola-Hess</surname>
							<given-names>S</given-names>
                            </name><name>
                            <surname>Brunner</surname>
							<given-names>G</given-names>
                            </name><name>
                            <surname>Krieg</surname>
							<given-names>T</given-names>
                            </name><name>
                            <surname>Smola</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<source>Myofibroblast 
differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically 
regulated by endogenous transforming growth factor-beta and interleukin-1. Am J 
Pathol. 2004 Jun;164(6):2055-66.</source>
        <pub-id pub-id-type="pmid">15161640</pub-id>
    <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63764-9</pub-id>
    <pub-id pub-id-type="pmcid">PMC1615767</pub-id>
  </element-citation>
</ref>
<ref id="B32"><label>32</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Sieweke</surname>
							<given-names>MH</given-names>
                            </name><name>
                            <surname>Bissell</surname>
							<given-names>MJ</given-names>
						</name>
					</person-group>
					<source>The tumor-promoting effect of wounding: a possible role 
for TGF-beta-induced stromal alterations. Crit Rev Oncog. 1994;5(2-3):297-311. Review.</source>
        <pub-id pub-id-type="pmid">7849089</pub-id>
    <pub-id pub-id-type="doi">10.1615/CritRevOncog.v5.i2-3.90</pub-id>
  </element-citation>
</ref>
<ref id="B33"><label>33</label>
  <element-citation>
    <person-group person-group-type="author">
    <name>
    <surname>Verrecchia</surname>
							<given-names>F</given-names>
                            </name><name>
                            <surname>Mauviel</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<source>Transforming growth factor-beta signaling through the 
Smad pathway: role in extracellular matrix gene expression and regulation. J Invest 
Dermatol. 2002 Feb;118(2):211-5. Review.</source>
        <pub-id pub-id-type="pmid">11841535</pub-id>
    <pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.01641.x</pub-id>
  </element-citation>
</ref>
		</ref-list>
	</back>
</article>